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The nematode worm Caenorhabditis elegans (C. elegans) is increasingly popular as a model organism
for aging studies as well as for testing antioxidants and other compounds for effects on longevity.
However, results in the literature are sometimes confusing and contradictory [1–4]. This review
introduces C. elegans as a model organism, discusses aspects that make it attractive for aging and
antioxidant research, and addresses some problems and potential artifacts.
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1.1. Caenorhabditis elegans as a model organism
The soil-dwelling nematode (roundworm) Caenorhabditis ele-
gans (C. elegans) is a small (adult size about 1 mm length), free-liv-
ing, bacteriovorus vermiform with a mean lifespan of around 20
days under laboratory conditions. Under these conditions, C. ele-
gans are predominantly (>99%) self-fertilizing hermaphrodites
and populations can be maintained effectively isogenic, since each
individual hermaphrodite produces approximately 300 clonal
progeny during the ﬁrst week of adult life [5]. C. elegans hermaph-
rodite adults contain 959 somatic cells, 302 of which are neurons.
The complete cell lineage is known, including those cells that un-
dergo apoptosis during development [6]. The C. elegans research
community has generated a library of mutant strains as well as
an extensive toolkit for the genetic manipulation of this organism.
C. elegans are transparent at all developmental stages and a large
number of green ﬂuorescent protein (GFP) reporter-gene strains
have been generated, making it possible to visualize anatomy,
developmental processes and many signalling pathways in realchemical Societies. Published by E
sity of Singapore, University
Kent Ridge Road, Singaporetime. Strains can be cryogenically preserved at 196 C [7] and
many mutant strains can easily be obtained from the C. elegans
Genetics Center (http://biosci.umn.edu/CGC/).
The C. elegans genome has been completely sequenced and con-
tains approximately 18 000 genes, many of which have human
homologs [8]. Double-stranded RNA (dsRNA) interference can be
accomplished relatively easily, i.e. by feeding worms with bacteria
expressing dsRNA for the gene of interest, thereby causing a loss of
function phenotype [9]. When C. eleganswas introduced as a model
organism by Brenner et al. over 30 years ago, it was intended
mainly as a convenient model for investigations into developmen-
tal pathways and neurobiology [7]. Since then it has become a
widely accepted model and discoveries made in C. elegans have
been awarded with Nobel Prizes in 2002 for work on the genetics
of organ development and programmed cell death, in 2006 for RNA
interference and in 2008 for work on GFP, some of it in C. elegans.
1.2. Worms and aging
Nematodes were soon appreciated as convenient model organ-
isms for aging research, in part due to their short lifespan, morpho-
logical simplicity, ease of maintenance and of genetic manipulation
[5,10,11]. While some aspects of human aging, such as increased
cancer risk or loss of stem cell function, are not easily modelled
in C. elegans, there is evidence that some key mechanisms of
aging may be ‘‘public”, i.e., likely to be conserved across largelsevier B.V. All rights reserved.
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of aging is free radical-mediatedmacromolecular damage andmito-
chondrial decline, centralmechanisms of aging proposed by the free
radical theory of aging (FRTA) [13,14]. Detailed review of the FRTA is
beyond the scope of this article, but can be found elsewhere [15–18].
However, below we outline some of the key C. elegans results in the
context of the FRTA (for a more extensive review, see [19]).
1.3. C. elegans and the free radical theory of aging
The FRTA states that endogenous reactive oxygen species (ROS)
cause aging. If this is true, then modulation of endogenous antiox-
idant defences or supplementation with antioxidants ought to be
promising strategies for delaying aging.
Some evidence from mutations affecting C. elegans lifespan sup-
ports the FRTA. For instance mev-1 mutants, which carry a muta-
tion that affects mitochondrial complex II and increases ROS
production, are hypersensitive to oxygen, show elevated levels of
oxidative damage, accumulate abnormal mitochondria and are
short-lived [20].
Conversely, many long-lived aging mutants show increased
resistance to oxidative damage [15,21,22]. The daf-2 mutants, car-
rying mutations in the C. elegans insulin/insulin-like growth factor
(IGF) receptor, are long-lived and express elevated levels of many
stress response and antioxidant genes, including at least one of
the two mitochondrial superoxide dismutase (SOD) genes (sod-3),
responsible for dismutation of superoxide into oxygen and hydro-
gen peroxide [23–26]. Expression of some of these antioxidant
genes, including sod-3, appears to be required for the full lifespan
extension associated with daf-2 mutations [24]. Another gene
whose expression is elevated in daf-2 mutants is gst-10, which en-
codes a protein involved in the detoxiﬁcation of the lipid peroxida-
tion product 4-hydroxy-2-nonenal (HNE). While overexpression of
gst-10 increases oxidative stress resistance and extends lifespan in
wild-type (WT) worms, RNAi silencing of gst-10 shortens lifespan
and increases HNE toxicity in both WT and daf-2 animals [27,28].
On the other hand, it has recently been reported that genetic
inactivation of any of the ﬁve forms of superoxide dismutase
(SOD) in C. elegans, does not lead to signiﬁcant shortening of WT
lifespan [29,30]. In fact, inactivation of the sod-4 gene encoding a
cytosolic form of SOD even causes lifespan extension in daf-2 mu-
tants, possibly suggesting a signalling role for superoxide in this
setting [29,30], although compensation by changes in other SOD
isoforms has also been shown [31], and so these observations need
to be interpreted carefully.
Overall, these results support the concept that antioxidants and
oxidative stress are relevant in aging, although, whether lifespan
extension depends on modulation of oxidative damage remains
to be proven. Loss of function mutations in the clk-1 gene, which
is necessary for the synthesis of coenzyme Q (CoQ), have also been
found to extend lifespan [32]. CoQ has antioxidant properties (at
least in vitro) but is also required for proper functioning of the
mitochondrial electron transfer chain (ETC) in C. elegans (see also
Section 3.1). The lifespan-extending effect of the clk-1 mutation
is therefore consistent with the large number of mitochondrial
ETC genes whose inactivation leads to lifespan extension as re-
vealed by RNAi screens [33]. However, these results are difﬁcult
to interpret. While reduction in membrane potential, for instance,
can reduce ROS production from the ETC [34], metabolic and com-
pensatory effects are difﬁcult to separate from these ‘‘indirect”
antioxidant mechanisms. Using an RNAi dilution strategy to mod-
ulate mitochondrial ETC gene expression, Rea et al. [35] showed
that decreased expression of several ETC genes during L3/L4 larva
stages results in complex target-gene and dose-dependent lifespan
effects. Reduction of expression beyond a gene-speciﬁc threshold
level (typically to 40–60% of WT levels) resulted in lifespan exten-sion of up to 70%. While some tradeoffs consistent with lowered
metabolism (smaller size, delayed development, lower fecundity)
were reported, no clear correlation of lifespan extension with oxi-
dative protein damage, nor modulation of lifespan extension by the
C. elegans oxidative stress response transcription factor (SKN-1)
was detected [35]. However, mitochondrial function, mitochon-
drial metabolism and mitochondrial ROS production were not di-
rectly determined.
In summary, genetic support for the causative role of ROS in
aging is suggestive but somewhat ambiguous in C. elegans. Never-
theless, there is reasonable evidence for age-dependent accumu-
lation of ROS-mediated damage products [36–38], mitochondrial
abnormalities and mitochondrial dysfunction as well as decreased
metabolic capacity [37,39–42] in C. elegans. Excellent tools exist
for the characterization of some of these age-dependent changes
[43].
Despite these issues, antioxidants are still often considered as a
promising strategy for modulating aging and extending lifespan.
However, antioxidant studies in mammals give ambiguous results
and are expensive (reviewed in [16,17]), hence the interest in iden-
tifying antioxidants with lifespan-extending efﬁcacy in C. elegans.
For this approach to succeed, methodological challenges must be
addressed. First, studies need to provide robust data on lifespan ef-
fects that can be reproduced in other laboratories and are free from
artifact. Second, the observed effects need to be attributable unam-
biguously to antioxidant efﬁcacy, which requires measurement of
oxidative damage in parallel with effects on lifespan. Some of these
challenges are discussed below.
Genetic differences can exist in independent isolates of ‘‘N2”
worms and signiﬁcant genetic drift, affecting, amongst other traits,
nematode lifespan, can occur when animals are maintained over
many generations under laboratory conditions [44]. It is therefore
important to regularly refresh lab cultures from frozen stocks, de-
rived after minimal passage from the CGC reference strains and to
backcross newly generated mutant strains into the CGC N2 male
stock [44]. More information on methodological considerations,
including advice on genetic inhomogeneity and drift can be found
in [45,46] online (www.wormbook.org), (http://biosci.umn.edu/
CGC) and (www.wormbase.org) as well as in print [47].2. Lifespan studies: simple or deceptively simple?
The relative ease and apparent simplicity with which lifespan
data can be obtained has led to an increasing number of investiga-
tors to use C. elegans. However, this apparent simplicity can belie
some of the complexities that exist. There is evidence from the lit-
erature as well as our own experiences that ensuring the robust-
ness of lifespan experiments can be challenging. For instance,
Melov et al. [1] reported that compounds designed as synthetic
superoxide dismutase/catalase mimetics (SCMs) could extend
mean nematode lifespan by more than 40% in liquid culture, sup-
porting the FRTA [1]. However, attempts at independent replica-
tion of these data, both using liquid culture and solid nematode
growth medium (NGM), have failed [3,4], although lifespan exten-
sion under the original culture conditions was later conﬁrmed by
some of the original investigators [2]. These compounds did not ex-
tend lifespan in other invertebrate systems [48,49].
The reasons for this discrepancy are unclear. One suggestion is
that the original culture conditions might have exposed animals to
elevated oxidative stress [46]. However, the lifespan of control
worms in the original report does not appear abnormally low
and treated animals appear long-lived compared to the typical life-
span under standard conditions (see Section 2.1.3). The SCMs, gi-
ven their complex chemistry, may have complex biological
effects and might more accurately be called ‘‘redox modulatory
Table 1
Mean lifespan reported for control animals in 12 studies designed to examine lifespan
effects of compounds or extracts. Studies were selected because they utilized N2 WT
worms and reported standard culture conditions (20 C, monxenic E. coli culture)
either on solid NGM (a) or in liquid medium (b). Means of controlling progeny is
indicated as either FUdR treatment or transfer of adults to fresh plates.







1 [80] FUdR (500 lM) NGM 21.9
2 [128] FUdR (50 lM) NGM 14.6
3 [129] Transfer every 2 days NGM 18.7
4 [130] Transfer daily NGM 17.1
5 [131] Transfer every 2 days NGM 18.4
6 [132] FUdR (40 lM) NGM 12.8
7 [127] Transfer daily NGM 12.4
8 [107] Transfer every 2 days NGM 16.7
9 [122] Transfer daily NGM 20
Mean ± S.D. 17 ± 3.2
(b)
1 [133] Transfer daily Liquid culture 21.1
2 [134] Transfer every 2 days Liquid culture 19.3
3 [135] FUdR (120 lM) Liquid culture 23.3
Mean ± S.D. 21 ± 2.0
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dismutase might generally not be as important a determinant of
lifespan as previously believed [30], the difference in outcome does
suggest that culture conditions might indeed have been unusual in
some way or that the observed effects might have been indepen-
dent of the supposed SOD mimetic efﬁcacy.
In fact, all laboratory culture conditions are far from ‘‘normal”
for C. elegans [50]. The general assumption, nevertheless, is that
aging mechanisms might be universal enough that they can still
be investigated as long as conditions are standardized. However,
the above example illustrates that even well established C. elegans
researchers might not easily come to a consensus regarding life-
span effects of compounds. Even when ‘‘standard” conditions are
used, a number of issues and challenges exist, some of which are
discussed below.
2.1. Speciﬁc points on lifespan studies
2.1.1. Generating and maintaining synchronized cultures
Synchronization of cohorts is vital for lifespan studies. Two
methods are commonly used. One is by hypochlorite treatment,
essentially dissolving gravid adults in bleach solution to leave only
eggs that then give rise to a synchronized cohort (for detailed pro-
tocols see [51]).
Smaller numbers of synchronized worms can be obtained by
placing a few gravid adults on a hatching plate, allowing them to
lay eggs for only a short period of time [52]. Apart from the smaller
numbers of offspring obtained, a potential issue with this ‘‘egg lay”
method is that great care needs to be taken to remove all of the
adults (by counting the number of worms placed/removed) and
that offspring derive from only a small number of individual adults.
Whichever approach is taken, synchronized offspring should sub-
sequently be randomly distributed to treatment plates, to avoid
systematic differences in bleach or egg lay batches. In a variation
on this method, eggs can be allowed to hatch in liquid culture in
the absence of food, leading to L1 arrested larvae. These arrested
larvae develop into highly synchronized adult cohorts upon expo-
sure to food [53,54]. While this approach can be used when a high
degree of synchronization is required (e.g. for investigations into
development), it should be appreciated that the same signalling
pathways that modulate stress resistance, dauer formation and
aging in C. elegans also govern this L1 arrest [55]. Even though
there is evidence that lifespan of starved L1 larvae (post re-feeding)
is conserved [56], the possibility cannot be excluded that early
starvation might affect some aspects of aging and stress resistance
later in life.
Once generated, synchronized cultures need to be maintained,
that is, offspring have to be prevented from overcrowding the
aging cohort. Three approaches are commonly utilized. The con-
ceptually easiest approach is to move adults, ideally daily, to fresh
plates until reproduction ceases [57]. The advantages are that no
drugs or mutant strains are required and the risk of confounding
factors is thereby reduced. One disadvantage, apart from a higher
workload, is that it is possible to accidentally transfer second-gen-
eration larvae along with parents. If not detected, this could cause
a dramatic artifact, particularly affecting maximum lifespan as the
second-generation worms will typically be between three and se-
ven days younger than the parent cohort. Every transfer carries
some risk of injury, death or loss of worms. If large batches of
worms have to be grown, transfer of individual worms is generally
not a practical option.
A second way of maintaining a synchronized culture is the use
of 5-ﬂuoro-20-deoxyuridine (FUdR) [54,58]. FUdR inhibits DNA
synthesis and kills dividing cells. Since cells of the adult worm
are largely post-mitotic, FUdR treatment kills larvae and prevents
progeny development but does not kill adults [11,54,58]. FUdRhas been shown to prevent progeny growth in both liquid culture
and on solid nematode growth medium (NGM) agar plates and has
been used at concentrations between 25 lM (in liquid culture) and
as high as 5 mM without evidence for a decrease in lifespan
[54,58,59]. In fact, FUdR treatment at 400 lM on monoxenic
NGM plates has been claimed to cause a slight (7%) increase in life-
span [54].
However, the timing of transfer is critical as the larva stages are
highly sensitive to FUdR. Therefore, nematodes should be trans-
ferred to FUdR plates only just before they reach maturity, that
is, shortly before they start laying eggs. If nematodes are trans-
ferred too early, severe abnormalities result [54,58,60]. If the co-
hort is transferred too late, offspring can hatch despite FUdR.
Moreover, even in adult nematodes there is evidence that FUdR
does affect some experimental parameters including causing a
slight reduction of pharyngeal pumping rates, changes in body size
and morphology and even that it increases superoxide dismutase
levels [54,58,60,61]. While FUdR therefore appears not without
side effects, it has been shown to have only mild lifespan effects
even at 5 mM [59]. There are also reports that key aspects of the
aging process in FUdR-treated animals are qualitatively unchanged
[39,54].
FUdR is today widely utilized on solid NGM at concentrations
between 40 and 500 lM (Table 1a). In some of our studies investi-
gating the effect of ‘‘antioxidant” plant extracts on lifespan, we
found that there were occasionally larvae that seem to escape
the action of FUdR at low concentrations (650 lM), possibly due
to its interaction with components of certain extracts. Our labora-
tory therefore currently utilizes FUdR at 200 lM and up to 500 lM
for compound screens. It seems advisable to keep FUdR levels to
the minimum that will reliably prevent progeny production in a gi-
ven setting.
A third method for maintaining synchronized cohorts utilizes
temperature-sensitive fertility or egg-laying mutant strains. These
mutants produce progeny normally at a permissive temperature
(typically 15 C or 20 C), but are sterile at a higher restrictive tem-
perature, typically 25.5 C [62]. Use of such strains has the advan-
tage that no drugs are required and that large batches of
synchronized worms can be grown relatively easily. However,
the mechanism of action of some fertility mutations has not been
fully elucidated and it is possible that they cause additional effects
on worm physiology. Also, worm lifespan is shortened at elevated
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ter. It is therefore possible that the higher temperatures required
might sometimes affect experimental results (see Sections 2.1.2
and 2.1.4). Furthermore, there have been suggestions that some
temperature-sensitive mutants are not entirely sterile at the
restrictive temperature but can produce up to 0.1 progeny per
adult [62,63]. While this might seem low, it could result in 10%
of the aging cohort actually being from the next generation. Since
maximum lifespan is often determined as the mean of the longest
living 10% of the cohort, this could cause signiﬁcant artifact [136].
2.1.2. Contamination and the need for strictly monoxenic culture
Lifespan/aging studies using rodents have had a long history
and some of the insights gained may be applicable to nematodes.
Thus, it has been pointed out that animals used for such research
should be housed under pathogen-free conditions to avoid con-
founding effects due to disease [64] or changes in gut ﬂora. Nem-
atodes are usually grown on monoxenic NGM plates or liquid
culture using as a food source the uracil auxotroph Escherichia coli
(E. coli) strain OP50, whose growth is limited on NGM plates [7]. It
is known that various pathogenic strains of bacteria can reduce
nematode lifespan and may even increase oxidative stress
[65,66]. However, treatment with antibiotics as well as inactiva-
tion of bacteria can extend nematode lifespan even on OP50 mon-
oxenic NGM plates, possibly due to some residual pathogenicity
even of OP50 [67–69]. Also, antibiotics can sometimes exert anti-
oxidant effects, and this must be borne in mind [16,70]. Usually
monoxenicity is therefore maintained without the use of
antibiotics.
While C. elegans can be maintained axenically, development,
fecundity and lifespan as well as metabolism and stress resistance
are all affected under such conditions, probably due to some nutri-
tional requirement for metabolically active microbes or an un-
known heat-labile component [71,72]. Heat- (e.g.: 65 C for
30 min [73]) or gamma-inactivated OP50 can be utilized to reduce
bacterial metabolism, for instance when compounds are tested
which might be metabolized by E. coli.
While the current consensus in the C. elegans community seems
to be that monoxenic OP50 E. coli culture at 20 C without antibi-
otics or antifungal agents constitutes ‘‘normal” conditions, this
poses demands on maintaining sterility. WT worms can live up
to 40 days at 20 C and any contamination has ample time to grow
and affect worm survival, especially in the later phases of lifespan
experiments. Even with great care, contaminations can occur
[58,62]; one occasionally encountered virulent mould is known
as ‘‘the orange death” [51]. In liquid culture fungal contamination
is a common problem and can occur even with the use of antibiot-
ics [58,62]. In lifespan studies, contaminations can be difﬁcult to
control, as old worms are likely to be killed if transferred repeat-
edly, making it difﬁcult to remove the contaminating organism.
This challenge is worsened when mutant strains are utilized at
their restrictive temperature, typically 25 C, where contamina-
tions tend to grow more rapidly. In addition to careful sterile
technique and frequent checking of stocks, a dedicated, well-
maintained horizontal laminar ﬂow hood for all worm handling
and microscopy is essential.
2.1.3. Food density
Caloric restriction (CR) is deﬁned as signiﬁcant reduction of cal-
orie intake relative to an ‘‘ad libitum” diet while maintaining ade-
quate intake of vital nutrients. CR has been shown to extend mean
and maximum lifespan across different animal species, to decrease
oxidative damage [74,75], and to delay the onset and progression
of age-dependent diseases, including diabetes, autoimmune dis-
eases, sarcopenia and cancer [74–76]. In nematodes, CR in its
strictest sense is not easily achieved as reduction of E. coli is likelyto reduce not only calories but also key nutrients. Restriction of
food/speciﬁc nutrients is referred to more generally as ‘‘dietary
restriction” (DR). Various forms of moderate DR, including restrict-
ing some individual vital nutrients, have been shown to extend
lifespan in C. elegans. DR has been achieved using methods such
as bacterial dilution of OP50 food stock on NGM plates or in liquid
culture, genetic reduction of food intake by pharyngeal pumping-
deﬁcient ‘‘eat” mutants, control of bacterial growth on NGM plates
as well as control of available nutrients in axenic culture
[5,71,77,78]. While there is general agreement that DR can extend
lifespan in C. elegans by 20–80%, there is still uncertainty regarding
the role of different signalling pathways [79]. An attempt has been
made to deﬁne optimized protocols for CR experiments [79].
While DR experiments are an important tool for research into
aging, unintended variations in food availability have the potential
to cause artifacts in terms of lifespan, markers of oxidative damage,
stress resistance as well as developmental schedule and fecundity.
Since C. elegans do not compensate for low food density by increas-
ing pharyngeal pumping, nutritional intake is proportional to bac-
terial cell density in the medium [79]. One approach to control cell
density directly is to grow OP50 E. coli overnight in liquid Luria–
Bertani medium at 37 C and to determine bacterial cell density
by spectrophotometer. Stocks can then be concentrated to the de-
sired cell density, aliquoted and frozen at 80 C until needed. This
is necessary if inactivated bacteria or antibiotics are to be used, as
overnight growth on NGM plates is not possible in this case. OP50
cell number density considered ‘‘ad libitum” on NGM plates varies
between labs [5,77,80]. We have found OP50 stock concentrated to
1010 bacterial cells per ml to work well, because it is well above DR
levels (see below) but low enough not to interfere with micro-
scopic observation. Others have considered ‘‘ad libitum” levels that
are lower (109 bacterial cells per ml) or higher (1011 bacterial cells
per ml) but signiﬁcant lifespan extension by DR was detected be-
low 108 cells per ml with starvation setting in at 107 bacterial cells
per ml [5,81]. Bacterial cell density should be consistent across
plates and between experiments.
After preparation, plates should be sealed and, especially when
intended for lifespan experiments, kept at 4 C for at most 3 weeks
(ideally less). C. elegans will consume and redistribute food on
NGM plates, necessitating the occasional transfer of worms onto
fresh plates, especially during the earlier phases of lifespan studies.
This should be done well before worms ﬁnish most of the available
food and become restricted. Ideally the number of worms should
be consistent between plates and plates should be from the same
batch to avoid systematic differences in food availability and/or
in the number of transfers required.
2.1.4. Hormesis
Exposure to low level stressors, including oxidative stress, can
up-regulate stress response mechanisms, compensating (some-
times even overcompensating) for the stress originally encoun-
tered. This phenomenon, known as ‘‘hormesis”, can result in
increased stress resistance, enhanced damage repair and some-
times lifespan extension in diverse species in response to a range
of stimuli [82]. In C. elegans, hormetic lifespan extension has been
shown in response to hyperoxia, increased ROS production, UV and
ionizing radiation and heat shock [83–88].
While hormesis, like DR, is an exciting avenue for research into
mechanisms of aging [82] unintended heat or oxidative stress can
lead to artifact. Lifespan extension and signiﬁcant changes in the
transcription of stress response genes have been shown after as lit-
tle as 2 h at 30 C [85]. Sometimes, especially when beginning
work on nematodes, no dedicated 20 C incubator is available
and improvised or ‘‘spare” (often old) incubators are used – even
wine coolers have been suggested for this purpose. Care must be
taken to ensure that temperatures are correct, do not ﬂuctuate
J. Gruber et al. / FEBS Letters 583 (2009) 3377–3387 3381when environmental temperatures change and are spatially homo-
geneous inside the incubator. Simple thermometers are often inac-
curate to within 1 C. Also be careful to avoid accidental heat
shock. The stage of a stereomicroscope can reach 30 C or above
if a ‘‘cold” light source is not used. Plates should never be placed
(even temporarily) on light-source boxes, close to monitors or
computer cases or any other device prone to heating up. Finally,
a Perspex box, laminar ﬂow hood or Petri dish in direct sunlight
can easily heat up to temperatures above safe levels. The opposite
problem can occur when NGM plates are stored at 4 C prior to use.
Do allow equilibration of plates to 20 C before transferring worms.
For oxidative stress, a different hormetic effect is of concern.
Pre-exposure to conditions inducing elevated oxidative stress can
cause up-regulation of endogenous ROS defence systems with sub-
sequent increased resistance to further oxidative challenge and to
other stressors. In some cases pro-oxidant treatments have been
shown to be associated with extended lifespan. For example expo-
sure of nematodes to the ROS-generator juglone [16] can lead to in-
creased levels of reduced glutathione (GSH) and extension of
lifespan [86]. In C. elegans, a major transcription factor mediating
the response to acute oxidative challenge is SKN-1, the C. elegans
ortholog of the mammalian Nrf2 transcription factor [89]. GFP-re-
porter-gene constructs have been generated that can be utilized to
detect, for example SKN-1 mediated antioxidant responses to puta-
tive pro-oxidant compounds [90].
In summary, nematodes do not maintain their body tempera-
ture and respond sensitively to changes in their environmental
temperature or elevated stress. Since elevated stress can be protec-
tive against endogenous damage and can cause lifespan extension,
great care needs to be taken to avoid artifacts associated with these
responses, especially when screening antioxidants and other puta-
tive lifespan-modulating compounds (see Section 3).
2.1.5. Operator bias
Human expectation affects subjective experience, judgment and
perception, mostly without the individual being aware of it. This
matters, for instance, in clinical trials where even the color of the
medication given can affect outcome, presumably through affect-
ing patient expectations [91].
In general, randomized trials without blinding tend to show
larger treatment effects than blinded studies [92]. Hence dou-
ble-blind, placebo controlled studies are standard in clinical
investigations. However, perceptions of scientist–observers in
laboratory settings are also inﬂuenced by what the observer be-
lieves that he/she knows. For example, observers provided with
two samples of Planaria worms, one of which was described as
‘‘low-response-producing” and the other as ‘‘high-response-pro-
ducing”, found on average 5 times more head turns and 20 times
more contractions in the supposed ‘‘high response-producing”
sample, despite the fact that both samples contained identical
Planaria [93]. Is there reason to believe that observer bias might
pose a problem for C. elegans lifespan studies? Observer bias is
particularly problematic if any element of the experimental set-
up is based on a subjective assessment (judgment). In C. elegans
lifespan studies, the observer has to decide at each time-point
whether each worm is still alive. Worm survival is typically
scored by touching each worm using a platinum wire (worm
pick). Worms are scored as alive if this elicits a response or dead
if it does not [52]. Old worms, however, become sluggish and are
often partially immobilized [94]. Moreover, old worms become
more prone to injury and can be killed by rough handling such
as vigorous and repeated prodding. Not only does the outcome
of survival scoring therefore depend on operator judgment, sur-
vival itself can be inﬂuenced by subtle differences in the care ta-
ken during scoring. Indeed, an additional death criterion (turgor
pressure) was considered necessary when lifespan studies wereﬁrst utilized but has since been largely discontinued [52]. Blind-
ing of lifespan studies, though having been pointed out as highly
desirable previously [45], does not seem to be routinely per-
formed in C. elegans (recent exceptions: [95,96]). In our own lab-
oratory, compulsory blinding of all C. elegans lifespan studies
was found to increase consistency between runs and between
operators. Randomization and blinding also prevent other poten-
tial confounders such as systematic timing effects. Treatment
and control plates should always be handled, scored and assayed
in parallel. For example, if control plates are always handled be-
fore (or after) treated/mutant plates, issues such as rising tem-
perature or decreasing operator alertness might systematically
affect outcome.
2.1.6. Some considerations regarding n-numbers
Lifespan studies are time consuming and can be tedious. It has
been estimated that an experienced investigator might, under ideal
conditions, be able to manually score 10 worms per minute [97].
However, in our experience, when taking into consideration over-
head time (unsealing and resealing plates, ﬁnding of lost worms) as
well as various forms of trouble-shooting (old or buried worms,
contamination, transfer if required), this can easily drop to 2–3
worms per minute.
High throughput systems for automated determination of life-
span have been described [97,98]. A well established and commer-
cially available system utilizes liquid worm culture and automatic
worm-handling technology (in liquid buffer) and allows determi-
nation of fecundity, growth, developmental stage and, utilizing a
ﬂuorescence dye (SYTOX green) in conjunction with online ﬂuores-
cence detection, determination of lifespan [97,98]. While these ap-
proaches allow lifespan studies with 100 000s of individuals and
open up the possibility of very large scale screens [99] as well as
novel insights into aging [100], the use of liquid culture suffers
from the drawbacks mentioned in Sections 2.1.2 and 2.1.3.
For manual scoring, there is often a trade-off between the num-
ber of animals used and the number of different conditions/strains
that can be tested. Some lifespan studies have been published
based on only 20–70 animals per repeat (although three repeats
are usually reported). Apart from basic consideration of power
analysis in terms of largest detectable effect, low n-numbers pose
additional problems.
For one, maximum lifespan is commonly assessed as the mean
lifespan of the longest living 10% of a given worm population. How-
ever, maximum lifespan is sensitive to right tail outliers in the sur-
vival distribution and even single worms can make a signiﬁcant
difference in sets with small sample size. In such sets, there are sim-
ply too few data to detect anything but major deviations from nor-
mality [101]. In other words, with small n-numbers, even if
normality is formally tested, it is difﬁcult to ensure that there are
no outliers that might affect statistical analysis. Any of the artifacts
discussed above can cause such deviations from normality. To ex-
plore the impact of sample numbers (worm count) on statistical
inference, we here utilize experimental data from one of our recent
studies. Two worm populations were considered: (a) untreated
wild-type (WT)N2and(b)wormstreatedwithanexperimentaldrug
(Fig. 1). This drug has repeatedly been shown in our laboratory to
have a small but signiﬁcant effect in increasingmean andmaximum
lifespan. Instead of choosing our ‘‘best” dataset, we choose this par-
ticulardataset (Fig. 1)because it exhibits typical featuresof real data.
In particular, therewere someunexplained early deaths in the treat-
ment group. While these were limited to 1 of 20 NGM plates, this
unexplained problem reduced statistical signiﬁcance particularly
with respect to the mean lifespan. Despite this problem, the data
passes Lilliefors test of normality at a signiﬁcance level of 5% [101].
Furthermore, Kaplan–Meier statistics show that the twowormpop-
ulations are distinct (P < 0.003) and that themaximum lifespan (de-
Fig. 1. Lifespan experiment showing the effect of an experimental drug ‘‘X” on age-
dependent survival of N2 C. elegans under ‘‘standard” conditions (20 C, monoxenic
live E. coli @ 1010 cells/ml, solid NGM plates). Lifespan curves show survival of N2
worms treated with the drug ‘‘X” (n = 183) in comparison to N2 control worms
(n = 174). The drug treatment caused a signiﬁcant increase in age-dependent
survival (log-rank test, P = 0.003). Maximum lifespan increased signiﬁcantly
(P < 0.03) from 28.4 to 30.3 days with drug treatment, while mean lifespan was
not signiﬁcantly different between treated (22.5 days) and control (21.6) animals.
Note the early deaths in the drug ‘‘X”-treated group (for details see Section 2.1.6).
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niﬁcantly longer in treated worms (P < 0.03).
We began this study with 220–250 worms per group to ensure
that even after losses we would obtain data from about 200 ani-
mals. To illustrate the impact that a smaller sample size would have
had, we randomly choose 10 000 separate subsets, each of 25, 50,
75, 125 and 150 worms from the treated and control groups and re-
peat the statistical analysis for all pairs of these subsets. Fig. 2 illus-
trates the result for maximum lifespan. At lower sample numbers
there is considerable overlap between the distributions. When only
25, 50 or even 75 worms are considered one is likely to detect no
effect at all and it is even possible to obtain an apparent toxic effect
(shortening of maximum lifespan). Fig. 3 shows that even when
100 worms are selected, the lifespan curves can only be reliably
identiﬁed as being signiﬁcantly different in 50% of the cases.
Effective n-numbers depend on the number of worms for which
an ultimate fate is known. Worms that crawl off plates, die of in-
jury or suffer internal hatching of larvae are usually excluded (cen-
sored). Therefore, in order to maintain statistical power, the
starting number of worms should be at least 10–20% higher than
the intended ﬁnal n-number. The number of worms that is appro-
priate depends on the size of the expected effect as well as the
amount of variability, but even for preliminary screening and dose
response studies we try to obtain data on at least 100–200 individ-
uals. As with all assays, at least three independent, blinded repeats
of any lifespan experiment need to be run before conclusions can
be drawn. Therefore, screening a single compound will usually re-
quire thousands of worms, each scored daily or every other day
over 20–40 days.
2.2. Do these challenges matter?
To explore the question of reproducibility in lifespan studies,
we surveyed compound screening studies reported between
1988 and 2009, revealing 12 studies that reported mean lifespanvalues for control (untreated) N2 WT worms under standard con-
ditions (20 C, fed on OP50). Nine of these were carried out on solid
NGM (Table 1a) and three in liquid culture (Table 1b). The data re-
veal a high variability under what are supposedly comparable as-
say conditions. Considering the NGM results, the values for mean
lifespan range from 12.4 days to 22 days, average 17 ± 3.2 days
(Table 1a). Indeed, the mean difference between labs (2.5 days) is
comparable in magnitude to the typical treatment effect reported.
Lifespan in the three liquid culture studies was somewhat longer
(average 21.2 ± 2.0 days). These data indicate that there is a signif-
icant lab-to-lab variability.
Some data from our own laboratory further serve to illustrate
some of the challenges discussed above. C. elegans work in our lab-
oratory was initially carried out in a shared facility lacking a ded-
icated horizontal laminar ﬂow hood, cold light microscope and
accurately-temperature controlled incubator. After transferring to
a dedicated nematode facility, we noticed an increase in mean
and maximum lifespan of our N2 controls from 18 and 28 days
to 22 and 30 days, respectively, plus a decrease in problems asso-
ciated with contamination. Moreover, we re-investigated lifespan
effects and associated ﬁtness tradeoffs of the polyphenolic phyto-
alexin resveratrol. Resveratrol was previously shown to extend
nematode lifespan [73], whereas others were unable to detect
any lifespan extension in C. elegans [96]. Using our original facility,
we found that resveratrol could extend mean lifespan by almost
50% while showing a ﬁtness trade-off in the form of delayed egg
laying [102]. However, in our dedicated nematode facility, the life-
span-extending effect of resveratrol, while still detectable, was sig-
niﬁcantly smaller, although the effect on egg laying remained
unchanged (unpublished observations). Thus confounded data
can result from suboptimal conditions.3. Testing antioxidants and other agents
C. elegans has been utilized for testing the effect of compounds
on lifespan for almost as long as it has been used as a model organ-
ism [103], and several lifespan-extending compounds have been
identiﬁed [46,104]. However, it has also been known for a long
time that ‘‘Drugs do not readily work on C. elegans” [105] meaning
that drug delivery, bioavailability and timing are often a problem
[46,106]. For example, the internal concentration of ethosuximide
in worms being treated with 2 mg/ml of this anticonvulsant drug
was found to be only 30 lg/ml, or 1.5% of the external concentra-
tion [107]. Secondly, E. coli are efﬁcient at metabolizing com-
pounds including many polyphenolics of interest with respect to
their putative lifespan modulatory efﬁcacy [46,108]. While the lat-
ter effect may be ameliorated by utilizing heat-inactivated bacte-
ria, these challenges pose the risk of failing to identify efﬁcacy
simply because a compound does not reach the tissue or compart-
ment of interest. It is therefore important to investigate this, espe-
cially when interpreting negative effects. If the compound of
interest targets a speciﬁc pathway or gene this can sometimes be
achieved using reporter-gene or knockout strains. For antioxidants,
a similar approach can also be utilized by showing lifespan exten-
sion in the mev-1 strain or under exogenous ROS challenge (for
more on conﬁrming antioxidant mode of action, see Section 3.1).
Of course, physiological effects are possible even if compounds
are not detectable in whole worm lysates. For instance the ASI sen-
sory neurons have been shown to be involved in lifespan extension
in response to caloric restriction in C. elegans [109]. Modulation of
sensory neurons by compounds might cause physiological changes
without these entering cells.
Drugs sometimes also have other indirect or artifactual effects
on lifespan. For example, compounds and extracts can affect the
growth of OP50 E. coli (if live bacteria are used) or of contaminating,
Fig. 2. Effect of sample size on maximum lifespan statistics when sub-sampling the experimental population of worms shown in Fig. 1. Sub-populations of between 25 and
150 animals were drawn from the original treated and untreated populations. The maximum lifespan of each of these sub-populations was determined as the average of the
longest surviving 10% in that sub-population and the statistical signiﬁcance of the treatment effect was determined for each pair of sub-populations (see Fig. 3). This process
was repeated in silico 10 000 times for each sub-population size (25, 50, 75, 100, 125 and 150 animals). The histogram with grey bars represents the wild-type control worm
populations while the white histogram represents the treated worm populations. Histograms show the distribution of maximum lifespan values within the 10 000
populations generated. The ‘‘mean”, ‘‘max” and ‘‘min” values are the average, largest and smallest maximum lifespan values found in the 10 000 sub-samples of the original
population. As expected, the degree of separation between maximum lifespan distributions of treated and control groups decreases with decreasing sample size, resulting in
increased uncertainty. Also, it is interesting to note that for sample sizes below 75, the degree of overlap between populations is large, illustrating that it is relatively likely to
detect an apparent toxic effect (although probably not statistically signiﬁcant), even though the actual effect is protective.
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fungal properties in addition to its alleged antioxidant activity[110]. Furthermore, many polyphenolic compounds are unstable
in culture media, for example generating hydrogen peroxide
Fig. 3. Frequency of in silico trials that show statistically signiﬁcant differences in
survival as consequence of treatment. The ﬁgure illustrates the expected result, that
the outcome of hypothesis testing has a strong dependence on sample size. The
frequency of statistical signiﬁcance was obtained for each sample size by comparing
each pair (treated vs. control) of the 10 000 sub-populations using Kaplan–Meier
analysis for inferring distinct populations at a signiﬁcance level of 0.05. The analysis
conﬁrms the visual impression (Fig. 2) that, for this particular experiment,
population sizes <100 would have yielded non-signiﬁcant results in over 50% of
cases.
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to such compounds may therefore be due to their oxidation prod-
ucts or due to hormetic effects (Section 2.1.4), e.g. of H2O2. Many
other compounds can act as mild stressors thereby inducing a hor-
metic response, which can affect gene expression patterns, stress
resistance, activity levels, fecundity and lifespan [86]. Foul tasting
or otherwise unpleasant compounds might affect feeding behavior
and reduce food intake, again potentially inducing DR. They may
also cause treated worms to crawl off plates, leading to systematic
differences between treatment and controls.
It can also be misleading to report effects on lifespan at a single
(the ‘‘most effective”) dose of a compound since there is often com-
plex concentration-dependency [80]. One example of this is an ex-
tract of the medicinal herb Psoralea corylifolia (PC) [113]
investigated by us for its putative antioxidant and lifespan effects
in C. elegans. PC shows some in vitro antioxidant capacity and, at
low doses, causes signiﬁcant lifespan extension. However, PC is
also an inhibitor of the proteasome, cell division and mitochondrial
function and at higher doses shows clear dose-dependent toxicity
and reduction in lifespan [80,113,114]. Dose response studies
should always be performed and reported.
3.1. Inferring antioxidant mechanisms
Many compounds are antioxidants in vitro (‘‘test-tube antioxi-
dants”) and the label ‘‘antioxidant” is often assigned based simply
on such in vitro efﬁcacy. However, there are well known challenges
in interpreting and extrapolating in vitro results to in vivo [80,112–
118] and many in vitro antioxidants show limited or no antioxidant
capacity in terms of reduction of oxidative damage in vivo [16,115–
118]. One must exercise care when inferring in vivo antioxidant
efﬁcacy or attributing lifespan effects to antioxidant action. In fact,
as redox active compounds, test-tube antioxidants have the
potential to act as pro-oxidants in certain settings [16,112,118].
Antioxidants may thus cause lifespan modulation by antioxidant-
independent mechanisms (including hormesis). In addition, if cul-
ture conditions induce elevated oxidative stress, treatment with
antioxidants may result in lifespan extension, but this observation
does not allow conclusions regarding antioxidant efﬁcacy againstendogenous ROS or anti-aging effects under ‘‘normal” conditions
(Section 2). Therefore, even if treatment with a potent in vitro anti-
oxidant causes signiﬁcant lifespan extension, this does not prove
an action by antioxidant mechanisms, nor does it provide support
for the FRTA. Several criteria should be met before concluding that
a direct antioxidant mechanism is responsible for an observed pro-
tective or lifespan-enhancing effect:
(i) Treatment, with the compound at the levels affecting life-
span should result in a dose-dependent reduction of oxida-
tive damage as evaluated by appropriate biomarkers of
oxidative damage (for discussion of biomarkers please see:
[16,117,119]). For C. elegans the best established marker of
oxidative damage to date is protein-carbonyl content (PCC)
[38], and perhaps lipofuscin [36,37] but others need to be
examined and we have yet to elucidate which are the key
targets of oxidative damage in this organism.
(ii) Compound treatment should be protective under conditions
of elevated oxidative stress, e.g. as induced by pharmacolog-
ical means (e.g. paraquat challenge), genetic mutation (e.g.
mev-1) or environmental manipulation (e.g. hyperoxia and
radiation).
(iii) Inhibition of the mitochondrial ETC or slowing of metabo-
lism can extend lifespan in C. elegans [33,35,120]. Therefore,
compound treatment should not disrupt mitochondrial
function, reduce metabolism, induce DR or inhibit nematode
activity.
(iv) Other antioxidant-independent mechanisms should also be
excluded. Compound treatment should not reduce pharyn-
geal pumping (potentially causing DR), should not delay
development or fecundity and should not induce stress
response pathways oxidative stress related or otherwise.
The latter is testable, for example, using GFP-reporter-gene
strains such as SKP1 related GFP strains [90] or the
hsp16.2::gfp strain CL2070 [115].
Numerous reports suggest antioxidant- mediated lifespan
extension, but in light of the discussion above, one may ask how
strong the evidence in C. elegans for lifespan extension by antioxi-
dants really is. The uncertainty surrounding the question as to
whether the superoxide dismutase/catalase mimetics (SCMs)
cause antioxidant-based lifespan extension, has been discussed
above (Section 2).
3.2. What about other ‘‘antioxidants”?
One of the ﬁrst to be explored was a-tocopherol (vitamin E),
now suggested by some [121] to have multiple effects in vivo in
addition to its antioxidant properties. In 1983, it was reported that
treatment with a-tocopherol extends lifespan when begun at larva
stage [103]. Although this work was carried out in axenic medium,
lifespan effects of a-tocopherol were later conﬁrmed on monoxe-
nic NGM plates [122]. However, lifespan extension was associated
with slowed development, suggesting that the effect might, at
least, in part be due to developmental delay [122,123]. There is lit-
tle evidence for in vivo antioxidant efﬁcacy of a-tocopherol causing
its effect on lifespan. Neither vitamin C alone nor vitamin C plus
vitamin E extended lifespan in C. elegans [122].
Treatment of WT worms with tocotrienols, compounds struc-
turally related to vitamin E, has been shown to result in lifespan
extension and reduction in age-dependent accumulation of oxida-
tively modiﬁed protein, determined as protein carbonyls
[124,125]. However, developmental timing or fecundity were not
assessed in these animals. Since protein-carbonyl levels increase
with age, it is possible that the reduction in protein carbonyls
was in fact secondary to any such developmental effects.
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CoQ10 and this treatment decreased superoxide anion production
in isolated mitochondria [123]. In the same study CoQ10 treatment
of WT worms resulted in an 18% increase in lifespan. Thus, it might
seem that CoQ has antioxidant efﬁcacy in vivo while at the same
time extending lifespan. However, paradoxically, depletion of some
forms of CoQ by dietary intervention or genetic means also extends
lifespan [32]. Considering that CoQ is an integral component of the
mitochondrial ETC, this suggests that the effects of CoQ on C. ele-
gans lifespan involve complex modulation of mitochondrial func-
tion in addition to (or perhaps instead of) a direct antioxidant
mechanism [126]. They may also depend on the exact form of
CoQ tested (for a more detailed review see [19]). Metabolic effects,
indirect antioxidant action (modulating ROS production) and direct
antioxidant action (detoxifying endogenously produced ROS) are
difﬁcult to distinguish when a putative chemical antioxidant is also
an ETC modulator or mitochondrial nutrient. Similar comments
may be made about the reported lifespan-extending effects of a-li-
poic acid [127].
As a further illustration, we performed an in vitro antioxidant
screen of 34 plant extracts and tested the six best to evaluate their
in vivo antioxidant capacities as well as effects on lifespan in C. ele-
gans [80,113]. We found that amongst the highest scoring in vitro
extracts, in vitro antioxidant capacities were a poor predictor of
in vivo antioxidant capacity [80]. We did, however, identify two
compounds with signiﬁcant effects on lifespan. Only one of these
(pine bark extract) showed efﬁcacy consistent with direct antioxi-
dant mechanism in all assays performed, while the other seemed
to modulate endogenous stress response pathways, possibly
through a hormetic mechanism.
In summary, the question as to whether antioxidants protect
against aging in C. elegans and, if so, whether they do this by anti-
oxidant and/or other mechanisms, is still open.
4. Conclusion
Many of the principles, challenges and artifacts that we have dis-
cussed are well known to researchers familiar with C. elegans. How-
ever, we hope that others will beneﬁt from this discussion, in
particular investigators ﬁrst using C. elegans for antioxidant and life-
span studies. Apart from remaining vigilant towards possible arti-
facts, trying to control the biological and physical environment as
well as possible, blinding all studies and using sufﬁciently large n-
number, one important advice is to record and report the details of
asmany of the relevant factors as possible. In particular, when inter-
preting and comparing lifespan results, it is important to know how
synchronized cohortsweremaintained, the exact culture conditions
including the type and density of bacteria used, the number of ani-
mals per plate or well, the number of animals censored (and why)
as well as the mean and maximum lifespan of controls.
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